CovInnovations

CovInnovations

Early Stage

The new standard of COVID-19 solutions.

The new standard of COVID-19 solutions.

Overview

Raised this Round: Raised: $4,297

Total Commitments ($USD)

Platform

StartEngine

Start Date

12/18/2022

Close Date

02/15/2023

Min. Goal
$15,000
Max. Goal
$1,234,986
Min. Investment

$244

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$7.40

Pre-Money Valuation

$49,980,000

Year Founded

2021

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Las Vegas, Nevada

Business Type

Growth

CovInnovations, with a valuation of $10.01 million, is raising funds on Startengine. They are focused on discovering and developing groundbreaking technologies that assess, diagnose, and treat COVID-19. CovInnovations has developed a potential cure for hospitalized patients with severe COVID-19 in need of oxygen supplementation. The Company is in the pre-revenue stage of development. Dr. Aury Nagy, M.D. FAANS founded CovInnovations in May 2021. The current crowdfunding campaign has a minimum target of $15,000 and a maximum target of $1,234,998.96. The campaign proceeds will be used for research and development and working capital.

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-831,753

$0

Summary Balance Sheet

FY 2021 FY 2020

Cash

$2,127

$0

Accounts Receivable

$72,348

$0

Total Assets

$74,476

$0

Short-Term Debt

$296,233

$0

Long-Term Debt

$609,996

$0

Total Liabilities

$906,229

$0

Financials as of: 12/18/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
CovInnovations on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $49,980,000
Price per Share: $7.40

Follow company

Follow CovInnovations on StartEngine 2022

Buy CovInnovations's Deal Report

Warning: according to the close date for this deal, CovInnovations may no longer be accepting investments.

CovInnovations Deal Report

Get KingsCrowd’s comprehensive report on CovInnovations including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether CovInnovations is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the CovInnovations deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge